Basolateral Amygdala Reactive Microglia May Contribute to Synaptic Impairment and Depressive-Like Behavior in Mice with Bone Cancer Pain

Neurochem Res. 2022 Nov;47(11):3454-3463. doi: 10.1007/s11064-022-03731-9. Epub 2022 Aug 24.

Abstract

Anxiety and depression induced by cancer-related pain disturb quality of life and willingness to survive. As a component of the limbic system, the basolateral amygdala (BLA) is critical for processing negative emotions. The reactive microglial engulfment of synapses may promote depression during adolescence. However, whether microglia phagocytose synapses to mediate cancer pain-induced depression remains unclear. The present study established a bone cancer-pain model to investigate the association between dendritic spine synapses and depressive-like behavior and explore the phagocytic function of microglia in the BLA. We found that tumor-bearing mice experienced postoperative pain-related depression, and their BLAs exhibited reactive microglia, as well as phagocytic synapses. The microglial inhibitor minocycline effectively mitigated depressive behavior, synaptic damage, and the phagocytic function of microglia. Our study implicates microglia-mediated synaptic loss in the BLA may act as the pathological basis of depressive-like behavior in bone cancer pain model.

Keywords: Basolateral amygdala; Cancer pain; Depression; Microglia; Synapses.

MeSH terms

  • Animals
  • Basolateral Nuclear Complex*
  • Bone Neoplasms* / complications
  • Cancer Pain*
  • Mice
  • Microglia
  • Minocycline / pharmacology
  • Quality of Life

Substances

  • Minocycline